Skip to main content
Back to OrbiMed

OrbiMed's Therapeutics Portfolio

Browse 85 Therapeutics companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
85
Total Funding in Therapeutics
$11.1B

Therapeutics Portfolio Companies (85)

Export
BiopharmaBiotechnologyGeneticsMedicalPharmaceuticalTherapeutics

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Dallas, United States
September 2025
$29.4M
Debt Financing

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Cambridge, United States
September 2023
$21.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health CareMedicalTherapeutics

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Dover, United States
July 2024
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

Health CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

New York, United States
July 2026
$23.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

London, United Kingdom
July 2022
$4.1M
Grant

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Lausanne, Switzerland
July 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
July 2026
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Cambridge, United States
July 2021
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyInnovation ManagementTherapeutics

Turnstone Biologics is a privately-held clinical stage biotech company.

La Jolla, United States
July 2021
$80.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Boston, United States
July 2025
$175.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Waltham, United States
June 2023
$200.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Austin, United States
June 2023
$210.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

Watertown, United States
June 2026
$65.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Boulder, United States
June 2026
$460.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

San Diego, United States
May 2025
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Rockville, United States
May 2026
$431.3M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

San Francisco, United States
May 2026
$1.3B
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

Vancouver, Canada
May 2022
$105.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Boston, United States
May 2023
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

San Diego, United States
April 2026
$137.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Cambridge, United States
April 2026
$180.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
$90.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Doylestown, United States
March 2026
$89.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

San Diego, United States
March 2024
$175.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Los Angeles, United States
March 2022
$10.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Princeton, United States
February 2026
$85.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Carlsbad, United States
February 2024
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

MedicalTherapeutics

Leal Therapeutics develops novel therapeutics for patients.

Worcester, United States
August 2025
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

41,000+ verified contacts

Health CareMedical DeviceTherapeutics

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

San Francisco, United States
January 2024
$40.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Paris, France
September 2023
$69.5M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Palo Alto, United States
January 2026
$200.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Cambridge, United States
January 2025
$207.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Lexington, United States
January 2024
$140.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Stamford, United States
December 2023
$275.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

La Jolla, United States
December 2024
$350.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareManufacturingTherapeutics

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

San Francisco, United States
December 2025
$70.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

San Diego, United States
December 2025
$84.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

San Francisco, United States
November 2025
$185.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

San Diego, United States
November 2025
$115.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

San Diego, United States
November 2025
$100.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Redwood City, United States
October 2025
$80.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Saint Laurent, Canada
October 2021
$101.2M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Cambridge, United States
October 2025
$155.3M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

South San Francisco, United States
October 2023
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

Natick, United States
October 2022
$35.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsTherapeuticsVeterinary

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

Philadelphia, United States
October 2021
$33.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Raleigh, United States
August 2024
$105.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.

Shanghai, China
January 2022
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

Cambridge, United States
May 2021
$86.4M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Philadelphia, United States
January 2021
$154.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Emendo is a biotechnology company

New York, United States
December 2020
$250.0M
Corporate Round

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Cambridge, United States
November 2020
$650.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalPrecision MedicineTherapeutics

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

San Diego, United States
October 2020
$460.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

Stevenage, United Kingdom
August 2020
$44.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

South San Francisco, United States
June 2020
$275.0M
Corporate Round

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

New York, United States
March 2019
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Dallas, United States
February 2019
$150.0M
Series E

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

Oakland, United States
October 2018
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders.

Ness Ziona, Israel
October 2018
$405K
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.

Stevenage, United Kingdom
August 2018
$32.6M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases

Basel, Switzerland
August 2018
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Arteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine.

Cambridge, United States
July 2012
$12.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio